Strychnos mitis
Strychnos mitis · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Strychnos mitis is a botanical species recognized for its significant medicinal potential in treating various health concerns. Research indicates that the leaves of this plant possess potent antimalarial and antiplasmodial activities. These bioactive properties have shown effectiveness in combatting malaria and specifically targeting Plasmodium berghei. Beyond its use in parasite control, studies have also explored the plant's influence on conditions related to weight loss. Consequently, this plant represents a valuable resource in the ongoing search for natural therapeutic agents.
- Synonyms
- Strychnos Adolfi-Friderici
- Common names
- Not available
- Family
- Loganiaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Strychnos mitis is a versatile plant known by several distinct common names across different regions. It is frequently referred to as the Pit-Leaved Strychnos, a name that highlights its unique botanical characteristics. In many areas, it is also widely recognized as the Yellow Bitterberry. Local variations of this name include the terms geel-bitterbessie and geelbitterbessie. Furthermore, the plant is known by the name umNono, reflecting its cultural significance.
Sources: Catalogue of Life (COL)
Synonyms
Strychnos mitis is a botanical species that is frequently identified in scientific literature by its formal synonym, Strychnos adolfi-friderici. This nomenclatural relationship highlights the evolving nature of plant taxonomy as researchers refine their classifications. Understanding these overlapping names is essential for botanists navigating various herbarium records and field studies. By recognizing both terms, experts can more accurately track the distribution and characteristics of this specific plant. Consequently, such synonymy ensures clarity and consistency within the broader study of botanical biodiversity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Strychnos mitis is a specialized member of the kingdom Plantae. This species is classified under the class Equisetopsida and belongs to the diverse order Gentianales. Within this botanical hierarchy, the plant is a prominent representative of the family Loganiaceae. It is further defined by its placement within the genus Strychnos. Through these distinct taxonomic layers, the plant's biological identity is clearly established.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Loganiaceae |
| Genus | Strychnos |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Strychnos mitis is a plant species with a broad distribution across the African continent. It can be found throughout East Tropical Africa, specifically within the borders of Kenya, Tanzania, and Uganda. The species also extends its reach into Northeast Tropical Africa, where it inhabits parts of Ethiopia. Furthermore, its presence is noted within the regions of Sudan and South Sudan. This diverse range highlights the plant's ability to thrive across various East and Northeast African landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Strychnos mitis is a distinctive tree species characterized by its robust, self-supporting growth form. This plant can vary significantly in scale, with smaller individuals reaching a height of at least 4 meters. However, it is most commonly recognized for its more substantial stature, typically growing between 18 and 35 meters tall. This impressive height allows the tree to establish a commanding presence within its natural ecosystem. Such structural diversity highlights the adaptable nature of this remarkable woody species.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Strychnos mitis has demonstrated significant antimalarial activity through recent in vivo studies involving Plasmodium berghei infected mice. Research indicates that various crude extracts and solvent fractions of the plant's leaves possess potent antiplasmodial properties. These extracts were able to significantly inhibit parasitaemia and prolong the survival time of infected subjects in a dose-dependent manner. Furthermore, the plant showed a capacity to prevent weight loss and maintain essential physiological functions like packed cell volume and body temperature. These findings provide strong scientific support for the traditional medicinal use of the plant and highlight its potential as a source for new antimalarial agents.
Compounds
Strychnos mitis has demonstrated significant potential in the fight against malaria due to its complex chemical composition. Phytochemical screening of its crude aqueous and hydro-methanolic extracts reveals the presence of several bioactive compounds. Specifically, the plant contains anthraquinones, glycosides, and phenols that may contribute to its medicinal properties. Furthermore, the presence of saponins and tannins supports its traditional therapeutic use in treating parasitic infections. These diverse secondary metabolites underscore the importance of further research into the plant's development as a novel antimalarial agent.
Conditions
Strychnos mitis demonstrates significant antimalarial potential by effectively treating malaria in infected subjects. The plant's extracts work to treat Plasmodium berghei, showing high rates of suppression in mice. Furthermore, Strychnos mitis treats parasitaemia by significantly inhibiting its presence. It also helps treat packed cell volume reduction through various crude and solvent fractions. Additionally, the plant treats temperature reduction, helping to stabilize physiological responses during infection.
Preparations
Parts used
Strychnos mitis possesses medicinal properties that are primarily concentrated within its leaves. Recent studies have focused on utilizing crude aqueous and hydro-methanolic extracts from these leaves to combat malaria. When tested in mice infected with Plasmodium berghei, various leaf fractions demonstrated a significant ability to inhibit parasitaemia. Furthermore, the leaf extracts helped prolong survival times and prevented critical physiological issues like weight loss and packed cell volume reduction. These findings strongly support the traditional therapeutic use of the plant's leaves and highlight their potential for developing new antimalarial agents.